Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Selegiline-containing product in transdermal dose form | Is a | Product manufactured as transdermal dose form (product) | true | Inferred relationship | Some | ||
| Selegiline-containing product in transdermal dose form | Has active ingredient | Selegiline (substance) | true | Inferred relationship | Some | 1 | |
| Selegiline-containing product in transdermal dose form | Has manufactured dose form | Transdermal dose form (dose form) | true | Inferred relationship | Some | ||
| Selegiline-containing product in transdermal dose form | Is a | Product containing selegiline (medicinal product) | true | Inferred relationship | Some | ||
| Selegiline-containing product in transdermal dose form | Plays role | Antidepressant therapeutic role | true | Inferred relationship | Some | ||
| Selegiline-containing product in transdermal dose form | Is a | Medicinal product acting as antidepressant agent (product) | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Selegiline 9mg/24hours transdermal patch | Is a | False | Selegiline-containing product in transdermal dose form | Inferred relationship | Some | |
| Selegiline 12mg/24hours transdermal patch | Is a | False | Selegiline-containing product in transdermal dose form | Inferred relationship | Some | |
| Selegiline 6mg/24hours transdermal patch | Is a | False | Selegiline-containing product in transdermal dose form | Inferred relationship | Some | |
| Selegiline only product in transdermal dose form | Is a | True | Selegiline-containing product in transdermal dose form | Inferred relationship | Some |
This concept is not in any reference sets